Coinfections by SARS-CoV-2 and other respiratory viruses and their clinical outcome
© 2021 Instituto Mexicano del Seguro Social..
Background: SARS-CoV-2 is a coronavirus described for the first time in China, in December 2019. This virus can cause a disease with a very variable spectrum that ranges from asymptomatic cases to deaths. The most severe cases are normally associated with comorbidities and with the age of the patient. However, there are patients who are not part of these risk groups and develop severe cases.
Objetive: To determine the association between coinfections by SARS-CoV-2 and other respiratory viruses and their clincal outcome.
Material and methods: RT-qPCR was performed to determine the presence of 16 respiratory viruses in 103 confirmed COVID-19 cases. Demographic and comorbid data were collected, and statistical analyzes were performed to determine associations with severity.
Results: Of the 103 analyzed cases, 14 (13.6%) presented a coinfection, of these, 92% did not require hospitalization, even in those cases in which the patient presented advanced age and some comorbidities.
Conclusions: These results suggest that coinfection of SARS-CoV-2 and other respiratory viruses is not related to a more severe form of COVID-19 and, in some cases, depending on the virus involved, it could even lead to a better prognosis. These findings lay the foundations for the development of new studies that could determine the biological mechanism of this phenomenon.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
---|---|
Enthalten in: |
Revista medica del Instituto Mexicano del Seguro Social - 59(2021), 6 vom: 01. Nov., Seite 482-489 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Coinfecciones por SARS-CoV-2 y otros virus respiratorios y su desenlace clínico |
---|
Beteiligte Personen: |
Fernandes-Matano, Larissa [VerfasserIn] |
---|
Themen: |
Coinfection |
---|
Anmerkungen: |
Date Completed 17.12.2021 Date Revised 17.12.2021 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM334446643 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM334446643 | ||
003 | DE-627 | ||
005 | 20231225223720.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||spa c | ||
028 | 5 | 2 | |a pubmed24n1114.xml |
035 | |a (DE-627)NLM334446643 | ||
035 | |a (NLM)34908381 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Fernandes-Matano, Larissa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Coinfections by SARS-CoV-2 and other respiratory viruses and their clinical outcome |
246 | 3 | 3 | |a Coinfecciones por SARS-CoV-2 y otros virus respiratorios y su desenlace clínico |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.12.2021 | ||
500 | |a Date Revised 17.12.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 Instituto Mexicano del Seguro Social. | ||
520 | |a Background: SARS-CoV-2 is a coronavirus described for the first time in China, in December 2019. This virus can cause a disease with a very variable spectrum that ranges from asymptomatic cases to deaths. The most severe cases are normally associated with comorbidities and with the age of the patient. However, there are patients who are not part of these risk groups and develop severe cases | ||
520 | |a Objetive: To determine the association between coinfections by SARS-CoV-2 and other respiratory viruses and their clincal outcome | ||
520 | |a Material and methods: RT-qPCR was performed to determine the presence of 16 respiratory viruses in 103 confirmed COVID-19 cases. Demographic and comorbid data were collected, and statistical analyzes were performed to determine associations with severity | ||
520 | |a Results: Of the 103 analyzed cases, 14 (13.6%) presented a coinfection, of these, 92% did not require hospitalization, even in those cases in which the patient presented advanced age and some comorbidities | ||
520 | |a Conclusions: These results suggest that coinfection of SARS-CoV-2 and other respiratory viruses is not related to a more severe form of COVID-19 and, in some cases, depending on the virus involved, it could even lead to a better prognosis. These findings lay the foundations for the development of new studies that could determine the biological mechanism of this phenomenon | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Coinfection | |
650 | 4 | |a Coronavirus Infections | |
650 | 4 | |a Respiratory Tract Diseases | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Monroy-Muñoz, Irma Eloisa |e verfasserin |4 aut | |
700 | 1 | |a Uribe-Noguez, Luis Antonio |e verfasserin |4 aut | |
700 | 1 | |a Hernández-Cueto, María de Los Ángeles |e verfasserin |4 aut | |
700 | 1 | |a Sarquiz-Martínez, Brenda |e verfasserin |4 aut | |
700 | 1 | |a Pardavé-Alejandre, Héctor Daniel |e verfasserin |4 aut | |
700 | 1 | |a Coy-Arechavaleta, Andrea Santos |e verfasserin |4 aut | |
700 | 1 | |a Alvarado-Yaah, Julio Elías |e verfasserin |4 aut | |
700 | 1 | |a Rojas-Mendoza, Teresita |e verfasserin |4 aut | |
700 | 1 | |a Santacruz-Tinoco, Clara Esperanza |e verfasserin |4 aut | |
700 | 1 | |a Grajales-Muñiz, Concepción |e verfasserin |4 aut | |
700 | 1 | |a Borja-Aburto, Víctor Hugo |e verfasserin |4 aut | |
700 | 1 | |a Muñoz-Medina, José Esteban |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revista medica del Instituto Mexicano del Seguro Social |d 2005 |g 59(2021), 6 vom: 01. Nov., Seite 482-489 |w (DE-627)NLM156363798 |x 0443-5117 |7 nnns |
773 | 1 | 8 | |g volume:59 |g year:2021 |g number:6 |g day:01 |g month:11 |g pages:482-489 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 59 |j 2021 |e 6 |b 01 |c 11 |h 482-489 |